AngioDynamics, Inc. Stock Analysis & AI Score
AngioDynamics, Inc. (ANGO) has an ST Score of 44.3 (C+), driven by its Momentum (A-) and held back by its Profitability (D-). Analysts rate it Hold with a $19.00 price target (+60.9% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIANGO Stock Price History
ANGO Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
ANGO Latest Stock News
ST Score
AngioDynamics, Inc. (ANGO) has an ST Score of 44.3 (C+), driven by its Momentum (A-) and held back by its Profitability (D-). Analysts rate it Hold with a $19.00 price target (+60.9% upside).
- Strongest
- MomentumA-
- Weakest
- ProfitabilityD-
All factor grades
- MomentumA-
- Financial StrengthB-
- ForecastB-
- ValuationC-
- GrowthD+
- ProfitabilityD-
- Piotroski5/9
Press Releases
Company Contact Details
ANGO stock: frequently asked questions
What is ANGO's ST Score?
AngioDynamics, Inc. (ANGO) has an ST Score of 44.3 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ANGO a buy, hold, or sell?
Analysts rate ANGO a Hold, with a price target of $19.00 (+60.9% vs the current price). Our ST Score grades it C+ (44.3/100). The ST Score is a data-driven signal, not a recommendation.
What are ANGO's factor grades?
Valuation C-, Profitability D-, Financial Strength B-, Momentum A-, Growth D+, Forecast B-.
What is ANGO's valuation grade?
AngioDynamics, Inc. (ANGO) earns a valuation grade of C-, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ANGO's growth grade?
AngioDynamics, Inc. (ANGO) earns a growth grade of D+, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ANGO's profitability grade?
AngioDynamics, Inc. (ANGO) earns a profitability grade of D-, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ANGO's financial strength grade?
AngioDynamics, Inc. (ANGO) earns a financial strength grade of B-, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ANGO?
The average analyst price target for AngioDynamics, Inc. (ANGO) is $19.00 from 11 analysts, which is +60.9% versus the recent price of $11.81.
What is ANGO's Piotroski score?
AngioDynamics, Inc. (ANGO) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.